Concord Medical Faces Revenue Decline but Eyes Growth
Company Announcements

Concord Medical Faces Revenue Decline but Eyes Growth

Concord Medical Services (CCM) has released an update.

Concord Medical Services Holdings Limited reported a decline in its financial performance for the first half of 2024, with total net revenues dropping by 23.1% and a net loss doubling from the previous year. Despite the downturn, the company remains optimistic, bolstered by its Guangzhou subsidiary securing a license for proton therapy equipment, which is expected to enhance revenue and growth in the oncology sector.

For further insights into CCM stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyConcord Medical trading resumes
TheFlyConcord Medical trading halted, volatility trading pause
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App